Pictet Asset Management (UK)’s Immunomedics Inc IMMU Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-1,231,955
Closed -$105M 1796
2020
Q3
$105M Sell
1,231,955
-1,122,931
-48% -$56.8M 0.16% 170
2020
Q2
$83.5M Buy
2,354,886
+973,520
+70% +$28.5M 0.14% 186
2020
Q1
$18.6M Buy
1,381,366
+86,031
+7% +$1.45M 0.04% 388
2019
Q4
$27.4M Sell
1,295,335
-484,481
-27% -$8.55M 0.05% 376
2019
Q3
$23.6M Buy
1,779,816
+404,670
+29% +$5.95M 0.05% 361
2019
Q2
$19.1M Buy
1,375,146
+133,795
+11% +$2.01M 0.04% 396
2019
Q1
$23.8M Buy
1,241,351
+223,350
+22% +$3.6M 0.05% 366
2018
Q4
$14.5K Sell
1,018,001
-19,080
-2% -$379K 0.04% 428
2018
Q3
$21.6M Sell
1,037,081
-268,058
-21% -$6.35M 0.05% 401
2018
Q2
$30.9M Sell
1,305,139
-294,970
-18% -$5.93M 0.07% 309
2018
Q1
$23.4M Sell
1,600,109
-18,965
-1% -$310K 0.06% 353
2017
Q4
$26.2M Buy
1,619,074
+517,611
+47% +$6.11M 0.07% 331
2017
Q3
$15.4M Buy
+1,101,463
New +$11M 0.04% 411

Pictet Asset Management (UK)'s IMMU Position: Q4 2020 in Review

Pictet Asset Management (UK) sold out of Immunomedics Inc (IMMU) in Q4 2020, closing a stake of 1,231,955 shares — an estimated $105M sold.

Pictet Asset Management (UK) first reported a position in IMMU in Q3 2017 and held it in 13 quarters. The position peaked at $105M in Q3 2020. 0 funds tracked by Wall St. Rank hold IMMU as of Q4 2020.

  • Pictet Asset Management (UK) reported no remaining Immunomedics Inc position as of Q4 2020 after selling out during the quarter.
  • Pictet Asset Management (UK) sold 1,231,955 Immunomedics Inc shares in Q4 2020, an estimated $105M.
  • Pictet Asset Management (UK) first reported a position in Immunomedics Inc in Q3 2017 and held it in 13 quarters.
  • Pictet Asset Management (UK)'s Immunomedics Inc position peaked at $105M in Q3 2020.
  • 0 funds tracked by Wall St. Rank held Immunomedics Inc as of Q4 2020.

Based on Pictet Asset Management (UK)'s 13F filing for Q4 2020, filed 16 Feb 2021.